Search

Home > The Bio Report > An Experimental COVID-19 Vaccine Begins Human Clinical Trials
Podcast: The Bio Report
Episode:

An Experimental COVID-19 Vaccine Begins Human Clinical Trials

Category: Business
Duration: 00:27:01
Publish Date: 2020-10-01 08:00:34
Description: United Biomedical has long been in the business of producing animal vaccines, but in recent years it has turned its attention to developing vaccines for chronic human diseases including neurological diseases, diabetes, and other targets. More recently it has used its vaccine platform to develop a multitope peptide COVID-19 vaccine and spun it out into a division dubbed COVAXX. We spoke to COVAXX co-founder and CEO Mei Mei Hu and COVAXX co-founder and Chairman Peter Diamandis, about the company’s efforts to develop a COVID-19 vaccine, how its peptide-based vaccine works, and the case for this approach. Since recording this interview, COVAXX began dosing participants in its phase 1 trial September 28, 2020.
Total Play: 0

Some more Podcasts by Levine Media Group

600+ Episodes